Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line

被引:18
作者
López-Coviella, I
Berse, B
Thies, RS
Blusztajn, JK
机构
[1] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA
[3] Genet Inst Inc, Cambridge, MA 02140 USA
关键词
BMP-9; choline acetyltransferase; SN56; cells; vesicular acetylcholine transporter; mouse; rat;
D O I
10.1016/S0928-4257(01)00080-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies showed that bone morphogenetic protein 9 (BMP-9) induces the expression of choline acetyltransferase and the vesicular acetylcholine (ACh) transporter, and upregulates ACh synthesis in cultured primary neurons from embryonic mouse septum [I. Lopez-Coviella, B. Berse, R. Krauss, R.S. Thies, J.K. Blusztajn, Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 289 (2000) 313-316]. In the present studies we investigated the effects of BMP-9 on ACh synthesis in the cholinergic mouse SN56T17 septal cell line. BMP-9 increased ACh synthesis in these cells up to 2.5-fold in a time- and dose-dependent, saturable manner. The maximal effect of BMP-9 was observed after a 3-day treatment and the median effective concentration of BMP-9 was 0.5 ng/ml. These data show that SN56T17 cells are a useful model for studies of the effects of BMPs on the cholinergic phenotype. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 76 条
[1]  
Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493
[2]  
Armes NA, 1997, DEVELOPMENT, V124, P3797
[3]  
Attisano L, 1996, MOL CELL BIOL, V16, P1066
[4]  
Barbosa J, 1999, J NEUROCHEM, V73, P1881
[5]   Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor [J].
Berse, B ;
Lopez-Coviella, I ;
Blusztajn, JK .
BIOCHEMICAL JOURNAL, 1999, 342 :301-308
[6]   Modulation of cholinergic locus expression by glucocorticoids and retinoic acid is cell-type specific [J].
Berse, B ;
Blusztajn, JK .
FEBS LETTERS, 1997, 410 (2-3) :175-179
[7]   COORDINATED UP-REGULATION OF CHOLINE-ACETYLTRANSFERASE AND VESICULAR ACETYLCHOLINE TRANSPORTER GENE-EXPRESSION BY THE RETINOIC ACID RECEPTOR-ALPHA, CAMP, AND LEUKEMIA INHIBITORY FACTOR CILIARY NEUROTROPHIC FACTOR SIGNALING PATHWAYS IN A MURINE SEPTAL CELL-LINE [J].
BERSE, B ;
BLUSZTAJN, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22101-22104
[8]  
BLUSZTAJN JK, 1992, J NEUROSCI, V12, P793
[9]   USE OF DIFFERENTIATED CHOLINERGIC AND 2ND-MESSENGER END-POINTS TO EVALUATE CHOLINESTERASE-INHIBITORS [J].
BLUSZTAJN, JK ;
DAVIS, RO .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (05) :368-369
[10]   BIOCHEMICAL-EVIDENCE FOR THE AUTOPHOSPHORYLATION AND TRANSPHOSPHORYLATION OF TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR KINASES [J].
CHEN, F ;
WEINBERG, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1565-1569